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Pathogenic  organisms  growing  in  the  dynamic  environment  of  the  host 
can be modified  by the mechanism of selection  or adaptation.  As a  result of 
the  host-parasite  interaction,  they  produce  substances  necessary  for  their 
survival in the host and therefore important in the pathogenesis of the infec- 
tion. When removed from the host to ordinary culture media,  the organisms 
may or may not continue  to synthesize these substances. This concept, first 
proposed by Bail and Weil (1), later revived and applied to the anthrax bacillus 
(2),  and  more  recently  effectively pursued  and  reviewed by Smith  (3),  has 
been  the  basis  of a  technique  designed to isolate factors responsible for the 
diverse sequelae of Group A streptococcal infections (4, 5). The method  also 
permits the study of toxic host factors which arise as a result of tissue damage 
(6, 7). 
By the  application  of  this  method  most  types of  Group  A  streptococci, 
grown in  the in vivo environment  of rabbit  skin,  produced a  soluble factor 
not readily obtained in vitro (4, 5).  When tested in American Dutch rabbits, 
the factor enhanced the lethal and cardiotoxic properties of typhoid endotoxin 
and  streptolysin O.  In  some respects,  the lesions  observed in  the  tissues of 
these  animals  resembled those characteristic  of the  generalized  Shwartzman 
reaction. The factor was relatively heat-labile, being partially destroyed when 
heated  at  56°C.  for 30 minutes.  Even though  antibodies were not found, it 
was antigenic  as manifested  by specific  immunization  against  its  lethal  en- 
hancing  activity. The  activity was not related  to any known factor derived 
from Group A streptococci. 
This communication describes additional toxic activities of these factors or 
toxins  and  distinguishes  three  distinct  immunologic  types.  Comparison  of 
* This investigation was supported  by a  research grant PHS-H-1797  from the National 
Heart  Institute,  National  Institutes  of  Health. 
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their  toxic  and  immunologic properties  with  purified  erythrogenic  toxins  of 
Type A  relate them to the important scarlet fever group of toxins. That these 
toxins play a  role,  previously unrecognized,  in  Group A  streptococcal  infec- 
tions and their non-suppurative sequelae will be suggested and discussed. 
Materials  and Methods 
Rabbits.--Young  American Dutch  rabbits  used  throughout  this  investigation weighed 
on the average 1 kg. They were supplied from a single source and fed a diet of Nutrenn rabbit 
pellets. 
History and Source of Streptococcal Cultures.---Organisms were maintained in the lyophilizecl 
state after one or more passages  through the skin of rabbits (8). All types, with the exception 
of T4-366,  became highly mucoid after animal passage.  T-28, NY-5, and T-17 came from 
NMRU-4, Great Lakes, Illinois; these came originally from Dr. Rebecca Lance~ld, of The 
Rockefeller  Institute. T-18, designated P-18, was isolated at NMRU-4, Great Lakes, Illinois. 
T-I9, made available by Captain John Seal, was isolated 1/29/53 at the USNTC, Bainbridge, 
Maryland, designated 089704 (Fu-7). T4-366 came from Dr. Ann G. Kuttner, Bellevue Hos- 
pital, New York. Group C-C74, originally obtained from NMRI, Bethesda, Maryland, came 
from NMRU-4. Type 12 is a nephritogenic strain supplied by Dr. Floyd Denny, Heart Hos- 
pital, University of Minnesota, Minneapolis. The Group B  was isolated from a  patient in 
the University Hospital, University of Minnesota. 
Preparation of Streptococcal Lesion Extracts  (SLE).--The  details for  the preparation of 
these extracts were given previously (4, 5). Briefly,  20 to 30 ml. of an 18-hour Todd-Hewitt 
broth culture containing 9.0 ×  107 organisms per ml. were injected intracutaneously at 40 
to 60 sites over the entire shaved abdomen and thorax of American Dutch rabbits. To obtain 
satisfactory preparations it is essential to distribute large numbers of streptococci throughout 
the skin. Rabbits are highly resistant to streptococci,  and one or two injections is not suffi- 
cient to overcome  the innate resistance of the host. These lesions,  when properly prepared, 
are not purulent but rather edematous with a high ratio of streptococci  to inflammatory cells. 
Mter 18 hours, moribund animals were killed and lesions excised and immediately frozen 
at --70°C. The partially thawed lesions were ground in a meat grinder at 5°C. and the meat 
and fluids suspended in cold saline at a ratio of 1 gin. of tissue to 1 ml. of 0.85 per cent NaC1 
solution. The mixture, after being stirred continuously for  12 to  18 hours at  2-4°C., was 
filtered through 4 layers of gauze to remove the tissue. The extract was then centrifuged at 
30,000 R.1,.m. (105,000 6") in the Spinco 30 head for 30 minutes at 2°C. The supernatant fluids 
were pooled, filtered through an 02 Selas filter, tested for sterifity, and finally dispersed in glass 
ampoules for storage at --70°C. After the lesions were removed from the rabbit, the material 
was not permitted to reach a temperature above 5°C. With these precautions, contamination 
with other microorganisms and their products which might interfere with the activity of these 
preparations did not occur. 
The numeral following the SLE designation represents the type of Group A streptococci 
used  in its  preparation. 
Endotoxins.--Endoto~dns  from Gram-negative bacteria used in the enhancement experi- 
ments and for cross-tolerance  were prepared as previously described  (4) from N~28-1 strain of 
Salmonella typhosa. This material was highly active for the production of the local Shwartz- 
man reaction. A purified endotoxin prepared by the method of Webster et al.  (9)  was  also 
used in similar experiments. 
Erythrogenic Toxin.--For comparative and enhancement experiments, a purified erythro- 
genie toxin 1014C was kindly supplied by Dr. Aaron H. Stock. Details of its preparation were 
previously published (10). It contained 1000 Lf per rag. total protein, and 1 Lf equalled about HOST-PARASITE FACTORS IN  GROUP A  STREPTOCOCCAL INFECTIONS  257 
60,000 s~. The material was dissolved in buffered saline and preserved with merthiolate at a 
concentration of 1 to 10,000. 
Scarlet Feter Antitoxin.--This  lot,  LP316F was obtained  by Dr.  Aaron Stock from the 
Wellcome Physiological Laboratories, Becken_ham, England. It contained 1760 units of anti- 
toxin by flocculation when tested with the above toxin. 
Recording of  Temperatures.--Rectal temperatures  were recorded on  a  tri-R electronic 
thermometer. Normal temperatures  were recorded prior to injection, and animals with ab- 
normally high temperatures, above 104°F., were not used. Food and water were not removed 
during the experiments. 
Modified Stock's Dialyzable Medium for Production of Streptococcal Exotoxin.l--Twenty-five 
pounds of whole fresh beef heart was defatted, cubed, and ground, giving a final weight of 
15 pounds. For each pound of meat, 400 ml. of pyrogen-free distilled water was added; the 
mixture was then stirred to give a uniform consistency. The tissue suspension, maintained in 
a water bath at a temperature  of 40°C., was solubilized by adding 1.6 gin. of Difco trypsin 
for each pound of meat. The pH was maintained at 8.0 by the frequent addition of 2.5 
NaOH; this required 50 ml. at intervals of 10 to 15 minutes with constant stirring. Digestion 
was considered complete when the pH remained at pH 8.0. At this stage, the tissue was highly 
solubilized, and the resulting  digest was poured  into Visking cellulose casing, size 36/32; 
sections 4 to 5 feet in length were readily filled through a funnel. These were coiled into 12 
liter pyrex bottles and immersed in pyrogen-free distilled water at a ratio of 2 liters for each 
pound of ground meat. The dialysis was continued at 1°C. for 48 hours. The dialysate was used 
for  the  medium;  the insoluble residue and high  molecular weight constituents  remaining 
inside the casing were discarded. The dialysate was sterilized by filtration through  2 liter 
capacity Seitz filters and collected aseptically in 3 liter Erlenmeyer flasks in volumes of 1.5 
liters  in each flask. 
Immediately before use, the medium was completed by the addition of 50 ml. of buffer 
to each liter of dialysate. The buffer contained glucose 3 gin., NaHCOa 2 gm., NaC1 2 gin., 
Na~HPO~. 12H20 2 gm., and l-glutamine 200 mg., dissolved in 50 ml. pyrogen-free distilled 
water.  Sterilization was accomplished by filtration through an 02 Selas filter. 
R.ESULTS 
Enhancement  of Lethal  and  Tissue-Damaging  Properties  of Stock's 
Erytkrogenic  Toxin  by Streptococcal  Lesion  Extract 
As  previously reported,  streptococcal  lesion  extract  (SLE)  injected  into 
American Dutch rabbits markedly alters the host-response as manifested by 
increased  susceptibility to  subsequent injections of  Gram-negative bacterial 
toxins and streptolysin O  (4, 5). The present experiment was designed to test 
in a  similar manner the effect of SLE on the lethal and tissue-damaging prop- 
erties of another streptococcal  toxin, erythrogenic or scarlet fever toxin. It is 
interesting to note that at the  time these experiments were done,  the active 
component of SLE had not been identified with erythrogenic toxin. A possible 
relationship was  not  considered because  SLE  was  heat-labile at  56°C.  and 
gave a negative skin test in American Dutch rabbits. 
1  1 am indebted to Dr. Aaron H. Stock, Department  of Microbiology, University of Pitts- 
burgh, for the basic method of preparing this medium. In addition, his generosity in making 
the toxins and antitoxins available for this study is gratefully acknowledged. 258  VE~r~n_S W. WATSON 
To establish the MLD of Stock's erythrogenic toxin for the enhancement 
experiments, it was titrated as outlined in Table I. These results show that 
the MLD, 25 Lf for a  1 kg. American Dutch rabbit, is about the same on a 
weight basis as previously given by Hotfle and Pappenheimer (11); they re- 
ported an MLD of 50 Lf for a  2 to 3 kg. chinchilla rabbit. For the lethal en- 
hancement experiment and  all  others using  sublethal  doses of erythrogenic 
toxin doses of 15 Lf were used. 
Table II gives the results of four experiments on the lethal enhancement 
of sublethal  doses of erythrogenic toxin. In  all experiments, the injection of 
TABLE I 
Titration of Stock's Erytkrogenic Toxin in American Dutch Rabbits 
Results  Time of death  Dose injected Lf  Protein  Death/total 
75 
50 
25 
20 
15 
10 
5 
mg. 
0.075 
0.050 
0.025 
0.020 
0.015 
0.010 
0.005 
2/2 
2/2 
2/2 
1/2 
O/2 
O/2 
O/2 
I1¢$. 
8 
14 
20 
12 
Less than 8 
Rabbits weighing 1 kg. were injected intravenously with toxin diluted in 0.85 per cent 
NaCI solution. 
SLE-18, 3 hours prior to the injection of the sublethal dose of toxin, modified 
the host-response toward the direction of greater susceptibility. As shown in 
subsequent experiments, this is a true enhancement and not an additive effect. 
It appears, therefore, that the lethal enhancement of toxins by SLE, as mani- 
fested in these experiments is a  general phenomenon and applies to a variety 
of toxins including  Gram-negative bacterial  toxins,  streptolysin O  and  now 
erythrogenic toxin. 
Histopathologic Studies~.--To compare the type and extent of tissue damage 
produced by erythrogenic toxin in normal and  SLE-treated animals,  tissues 
from the various groups of animals recorded in Table II were examined. 
• In the gross, the same degree of focal necrosis in the hearts and liver was 
observed after treatment with erythrogenic toxin as formerly observed with 
I am indebted to Dr. Joel Brunson of the Pathology Department, University of Minne- 
sota, for the microscopic  observations and hi  s cooperation  and assistance with the pathologic 
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typhoid toxin and streptolysin O (4, 5). As confirmed by microscopic examina- 
tion, there was less kidney pathology  than observed with streptolysin O and 
perhaps more liver damage and mitral valve involvement with  erythrogenic 
toxin. Bilateral renal cortical necrosis, characteristic of the generalized Shwartz- 
man reaction, was not a feature of this reaction. 
Structural changes were limited almost entirely to the heart and liver.  No 
qualitative differences were observed in the animals given 15 Lf of erythrogenic 
toxin in a  single injection as compared with those given SLE 3 hours before 
TABLE II 
Lethal Enhancement of Stock's Erythrogenic Toxin by SLE-18 in Rabbits 
Experiment  First injection  Second injection  Results  Deaths/total 
I, II; and III 
IV 
SLE-18 
0.5 ml. 
Saline control 
0.5 ml. 
SLE-18 
0.75 ml. 
Saline control 
0.75 ml. 
Stock's erythrogenic toxin 15 Lf 
Stock's erythrogenic toxin 15 Lf 
13/15 
o/15 
4/5 
0/S 
All injections were given in the marginal ear vein. The second injection was given 3 hours 
after the first. Time of death varied from 3 hours to 24 hours. Tissues, including heart, liver, 
kidney, and lungs were fixed in formadin-alcohol  solution for histopathologic  studies. All sur- 
vivors were killed on the 4th day. Saline control was an 0.85 per cent NaC1 in pyrogen-free 
water. Each experiment consisted of 10 animals, 5 test and 5 controls. 
the toxin, although in the latter group the lesions appeared somewhat  more 
extensive. 
Both valvular and myocardial lesions were present in the heart. The valvular 
changes consisted of thickening and some increased cellularity. The thickening 
was  associated  with  the  presence of a  fibrillar,  slightly basophilic  material 
which  was  slightly metachromatic  when stained  with  toluidine blue.  It  did 
not, however, give a positive reaction when stained by the periodic acid-Schiff 
method. The cellular components, limited usually to aggregates  just beneath 
the  valvular  endocardium,  consisted  of  mononuclear  cells  with  occasional 
heterophiles (Fig. 1). 
Extensive areas of muscle necrosis were observed also.  In some areas  this 
was accompanied by calcification of the necrotic myofibers (Fig. 2) with little 
evidence of inflammatory reaction. In other areas, the necrosis was associated 
with a  pronounced cellular reaction (Fig. 3), which consisted of large mono- 
nuclear cells and occasional heterophiles. These areas bore no constant rela- 260  DENNIS  W. WATSON 
tion  to  intramural  arteries  but were  observed more  commonly in  sections 
from the interventricular septum and the papillary muscles of theleft ventricle. 
Focal to diffuse areas of hepatic necrosis  were noted commonly. The  focal 
areas had no predilection for any particular part of the lobule and consisted 
of small necrotic areas with an accompanying mononuclear cellular  reaction. 
The diffuse areas commonly involved several lobules of the liver and consisted 
of frank infarcts accompanied by a  classic reaction zone of hemorrhage,  mono- 
Injected  I.V. 
5  15 t.F  exotoxin (Stock) 
Injected  I.V. 
0.75 rnl.  //  /,--  ~.o,,,~ 
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TgxT-FIG. 1.  Febrile response of rabbits  to SLE-18.  Five rabbits  were each given 0.75 
nil. SLE-18 intravenously. Rectal temperatures taken at hourly intervals when plotted against 
time show biphasic curves. Lethality of erythrogenic toxin was markedly enhanced as shown 
by death of 4 of the animals in 3 hours after the injection of a sublethal dose. 
nuclear, and heterophilic cells (Fig.  4).  No thrombi, however,  were observed 
in any sections from the liver. 
From these studies, it is evident that erythrogenic toxin  given in a  single 
injection  can  bring about marked  tissue destruction.  In  animals  pretreated 
with  SLE,  however, erythrogenic  toxin is more  destructive,  as manifest  by 
greater lethality and quantitative tissue damage. 
Pyrogenicity as  a  Measure  of SLE  Toxicity 
Increase in serum transaminase  after intravenous  injection of SLE, given 
in a preliminary report (12), indicated a primary toxicity of SLE preparations; HOST-PARASITE  ]~ACTORS IN  GROUP  A  STREPTOCOCCAL  INFECTIONS  261 
no doubt the release of this enzyme into the serum was a  manifestation of the 
tissue damage observed in the preceding experiment.  This observation,  along 
with Stetson's report (13)  of the pyrogenic nature  of streptococeal endotoxin, 
made it imperative to test the SLE preparations for their pyrogenic effects. 
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TEXT-FZG. 2. Development  of specific immunity to SLE-28 toxin determined  by febrile 
response. Twenty rabbits each received daily intravenous injections of 0.5 ml. of SLE T-28-1. 
Rectal temperatures  were recorded before and 3 hours after injection to give the 3 -- 0 hr. 
values recorded. Solid circles, above the line drawn at I°F., indicate fever. Clear circles, below 
the line, are within the normal variation which can occur with this breed of rabbit and under 
the conditions of the experiment. The rabbits developed immunity on the 5th day as indicated 
by the absence of fever. On the 6th day as a control, the rabbits received a different prepara- 
tion, SLE-28-2. On the 7th day, they were divided into 2 groups; one group was given the 
homologous SLE-28-1 and the other a heterologous SLE-18. Specific immunity to SLE-28 
is evident by the absence of fever in the group compared with the fever observed in those 
receiving the SLE-18. On the 10th day all received the homologous SLE-28-1 and again the 
majority were immune. On the 11th day, 10 of the original 20 received a pyrogenie dose of 
typhoid endotoxin (10 #g.) and responded comparably to an equal number of normal animals. 
Injection  of  0.75  nil.  quantities  of  SLE-18  intravenously  into  American 
Dutch  rabbits  produced  biphasic  temperature  curves;  these  were  typical  of 
those  described  by  Beeson  (14)  for  Gram-negative  bacterial  toxins  and  by 
Stetson (13) for the endotoxins of Group A streptococci. Text-fig. 1. shows that 
a  maximum temperature response occurs in 3 hours and, if the animals receive 262  DENNIS  W.  WATSON 
a sublethal dose of erythrogenic toxin at this time, death occurs within 6 hours. 
It is interesting to note that in previous experiments we had empirically selected 
3 hours as the optimum time to show lethal enhancement of toxins when SLE 
was given intravenously; at this  time both  serum  transaminase production 
(12) and fever response are at a maximum. 
Development of Specific Immunity to SLE as Demonstrated by Febrile 
Response to SLE-18  and  Typkoid Endotoxin 
The  febrile  response  noted in  the previous  experiment  could  have  been 
activated by a  number of contaminating pyrogens such as Stetson's strepto- 
4 
0 
2 
E 
t- 
oO 
I 
-I 
2  - 
80o 
OO 
o• 
0.  %%%0  -- 
ooo 
0  O0 
0 
000 
Immune  =Response  Immune  Response 
to  t-28  "to  t-18  to  t-18"Pto  t-28 
T~xT-FIO.  3.  Immunologic specificity of SLE-toxlns determined  by cross-lmmunlzation 
with SLE-28 and  SLF~18.  Twelve rabbits  were immunized by repeated daily intravenous 
injections of 0.5 ml. of SLE-28. When immune, as indicated by their fever response, they were 
given 0.75 ml. of heterologous SLE-I8. Another 12 rabbits were immunized with 0.75 ml. of 
SLE-18 and when refractory tested for their response to the heterologous SLE-28. The same 
preparations and concentrations were used for both groups of animals. 
coccal endotoxin (13) or the endogenous pyrogen of Landy and Shear reported 
to be present in high concentration in rabbit skin (15). All of these have one 
property in common--they produce a non-specific tolerance first described  by 
Beeson  (14). Animals  which receive  daily injections  develop  a  non-specific 
"immunity" within 6 to 7 days. In the present studies,  therefore,  reliance has 
been placed on the development of specific immunity to differentiate between 
SLE and other pyrogenic toxins. Text-fig• 2. gives the results of such an experi- 
ment. 
Even though the immunity developed  within the same  period  of time as 
observed for the Beeson tolerance,  the resistance  developed was by no means HOST-PARAsrI"E  FACTORS  IN  GROUP  A  STREPTOCOCCAL  INFECTIONS  263 
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T~xT-FIo. 4. Immunologic specificity of immunity to SLE-18 shown by cross-immuniza- 
tion with typhoid endotoxin. Each point, in the above biphasic fever curves taken over a 3 
hour period, represents the average temperature of 5 animals. Animals received all injections 
intravenously, and the same lots of SLE-18 and typhoid filtrate were used throughout  the 
experiment.  The  1st  curve  in the  top  series represents the response of normal animals to 
SLE-18. The 2nd fever curve in the top series is that obtained after the 5th injection; tem- 
peratures returned  to normal in 3 hours, indicative of the immune state.  One day after the 
last injection of SLE-18, the animals received typhoid endotoxin; the 3rd curve in the top 
series is typical of that given by normal animals as seen in the  1st curve, bottom series-- 
indicating the specificity of the immunity to SLE-18. Another group of animals were given 
5 injections of typhoid endotoxin over a 15 day period. When tolerant, as shown in the 2nd 
curve in the bottom series, and 1 day after the last injection of typhoid endotoxin, each maimal 
received SLE-18; the 3rd curve in the bottom series is typical of those obtained with normaI 
animals as shown in the 1st curve of the top series. 
non-specific when tested with the heterologous SLE-18 or a  pyrogenic dose of 
typhoid endotoxin. One might criticize this experiment on the basis of concen- 
tration differences between immunizing dose of toxin and the dose contained 
in the  heterologous challenges. To  overcome such  criticism, complete cross- 
immunization experiments were  done between SLE  preparations of different 264  DENNIS W. WATSON 
immunologic  specificity  and  between  SLE  preparations  and  typhoid  endo- 
toxin. 
Results of a  typical cross-immunization experiment are given in  Text-fig. 3. 
The  results  dearly  indicate  that  SLE-28  and  SLE-18  are  immunologically 
distinct toxins. 
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Tzxz-Fm. 5. Specific  neutralization of the pyrogenic activity of SLF,-toxins by commercial 
scarlet fever antitoxin.  The febrile responses given in the 1st and 2rid groups represent  the 
activity of 0.8 ml. of SLE-28 when injected intravenously into each of 10 rabbits and 0.5 ml. 
of SLE-18 when injected into each of 8 rabbits.  Each dose of SLE was mixed with 0.2 ml. 
of 0.85 per cent NaCI solution (saline). The 3rd group is the individual temperature  responses 
of 10 rabbits which received 0.8 ml. SLE-28 mixed with 100 units of commercial antitoxin in 
0.2 ml. of 0.85 per cent NaC1 solution, before intravenous injection. The 4th group represents 
the temperature  response of 10 rabbits  injected intravenously  with 0.5 ml. of SLE-18 plus 
100 units of antitoxin; the 5th group is the antitoxin control, and each animal received 0.5 ml. 
of 0.85 per cent NaCI solution containing  100 units  of antitoxin.  Antitoxin  and SLE were 
mixed and incubated 30 minutes at room temperature before injection. 
A  similar  experiment  was  repeated  using  SLE-18  and  typhoid  endotoxin. 
Text-fig.  4  gives  the  results.  From  these,  one  can  conclude  that  unlike  the 
Beeson  tolerance,  characteristic  for  Gram-negative  bacterial  endotoxins  and 
other pyrogens, immunity developed against SLE-toxins is specific and confers 
no protection against Gram-negative bacterial toxins. 
Specific Neutralization  of Pyrogenic Effects of SLE-28 with a Commercial 
Scarlet Fever Antitoxin 
Another  criterion  for identifying pyrogens,  characteristic  of endotoxins,  is 
the failure of antisera to neutralize specifically their pyrogenic effects. HOST-PARASITE  FACTORS  IN  GROUP  A  STREPTOCOCCAL  INI~ECTIONS  265 
Pyrogenic activity of SLE-toxins,  as shown in Text-fig.  5,  are specifically 
neutralized  by a  commercial  scarlet  fever antitoxin.  It  will  be noted  that 
this antiserum neutralizes only the SLE-28 and not SLE-18.  As already shown 
in Text-fig.  3,  SLE-28 and  SLE-18 are immunologic  distinct  toxins,  and  it 
will be shown later that SLE-28 has the same immunologic  specificity as Stock's 
erythrogenic A toxin and that the SLE-18 is a new toxin designated C. Com- 
mercial scarlet fever antitoxin is prepared by immunization of horses against 
the A  toxin,  and it would not be expected to contain  the C  antitoxin;  this 
latter toxin,  so far, is produced only by a Type 18 streptococcus. 
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TExT-FIo.  6.  Relative  SLE-toxin production by hemolytic streptococci  of Groups A, B, 
and  C.  The  1st  group  gives  the individual temperature  responses  of  10  rabbits  after  each 
received 0.5 ml. of SLE-18 from Group A streptococci;  the 2nd and 3rd groups represent the 
temperature  responses  after each animal received  1.0 ml. of SLE prepared  with Groups  B 
and  C  streptococci  respectively. 
Distribution of SLE-Toxins within the Lancefield Groups A, B, and C 
In previous experiments 2 distinct immunologic  specific toxins were demon- 
strated; one was produced by Type 18, the other by Type 28 and both were 
within the Group A streptococci. It was of interest, therefore, to determine if 
similar pyrogenic toxins were produced by other Lancefield groups of hemolytic 
streptococci. SLE preparations  using  Groups B  and C  organisms  were made 
in a manner comparable to that described for Group A. The lesions were highly 
edematous and  in physical appearance were quite similar  to those produced 
by the Group A streptococci. Results given in Text-fig.  6 show that SLE prep- 
arations made with Groups B  and  C  streptococci failed to induce significant 
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Since only 2 strains were tested for SLE toxins within Lancefield groups other 
than A, it cannot be concluded that these toxins are restricted to Group  A. 
These results are suggestive, and further testing will be carried out in additional 
strains within these and other groups. 
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T~xT-Fm. 7. Duration of immunity and demonstration of the anamnestlc response to 
SLE. Ten rabbits were each given daily injections of 0.5 ml. of SLF_~12  for 7 days. The same 
dose was given on the 18th and 19th day. 
Durat$on of Immunity  to SLE  Toxins  and  the Demonstration of an 
Anamnestic  Response 
Animals  given daily  intravenous  injections  develop specific immunity  to 
the SLE-toxins within 5 to 7 days. Undoubtedly, a small amount of antibody 
will neutralize the toxin in SLE. Because the toxins are placed directly into 
the blood stream and because they act rapidly, it is necessary to have circu- 
lating antibody present to demonstrate immunity. In other words, if antibody 
is not present, the toxins can exert their injurious effects before the anamnestic 
response can bring forth sufficient antitoxin to neutralize their activity. The 
results given in Text-fig. 7 confirm these predictions and show that after 18 
days  the  animals  become less  immune  to  intravenous  injection  of  SLE  as 
manifest  by a  significant temperature response.  Challenge  on  the  following 
day reveals complete immunity and demonstrates a rapid anamnestic response 
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Pyrogenici@ of 3rock's Erythrogenic Toxin and  Its Lethal Enhancement of 
Typhoid Endotoxin 
Specific neutralization of SLE-28 pyrogenicity by commercial scarlet fever 
antitoxin suggested a  relationship between the SLE-toxin and  erythrogenic 
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TEX'r-FXG. 8.  Pyrogenicity of Stock's  erythrogenic toxin and its lettml enhancement of 
typhoid endotoxin. Four rabbits were each given intravenously 5 Lf of Stock's exotoxin dis- 
solved in 0.5 ml. of 0.85 per cent NaCI solution. A similax  number of rabbits served as a contro! 
group, ~nd each received 0.5 ml. of 0.85 per cent NaCI solution (sa~e). After 3 hours aU of 
the rabbits were given a sublethal dose, 0.2 ml. of typhoid endotoxin (filtrate) intravenously. 
A complete titration of this toxin in groups of 5 rabbits for each dilution showed that a minimal 
pyrogenic  dose  was  0.125  Lf. 
toxin.  Such antisera, however, are prepared by the injection of heterogeneous 
materials and might contain antibodies to several streptococcal products. 
Results given in Text-fig.  8 show that a known purified erythrogenic toxin 
and SLE have similar activities as manifest by the fact that small quantities 
of erythrogenic toxin can induce the biphasic fever curves comparable to those 
observed  for  SLE-toxins  (Text-fig.  1).  In  addition,  the  results  show  that 
erythrogenic toxin, like SLE, enhances the lethal and tissue-damaging prop- 
erties of other toxins including typhoid endotoxin. Those animals which received 268  DENNIS  W.  WATSON 
both erythrogenic toxin and typhoid toxin and survived longer than 24 hours 
showed the typical myocardial and  liver necrosis observed  in animals given 
SLE. The control animals which received saline and typhoid endotoxin showed 
no gross pathology when examined 3 days after injection. 
Differentiation  of Erytkrogenic Exotoxin  (Stock)  and  Typhoid Endotoxin 
by  tke Local Shwartzman  Reaction 
The pyrogenic activity of any product might be attributed to contamination 
with Gram-negative bacteria and their active  endotoxins. In the last experi- 
ment, the biphasic temperature curves and the lethal enhancement of  toxins 
are properties  of Gram-negative bacterial  toxins which could  be present  in 
TABLE  III 
Differentiation  of  Gram-Negative  Toxins  (Typhoid)  and  Streptococcal  Exoloxln  (Stock)  by 
Means of the Local Skwartzman Reactions 
First injection intradermally 
Erythrogenic toxin (Stock), 5 Lf  ....... 
Typhoid endotoxin,  0.2 ml  ............. 
None ~  .............................. 
None ............................... 
None ............................... 
Second injection 
typhoid endotoxin 
intravenously 
18 brs, later 
ml. 
0.2 
0.2 
0.2 
0.5 
1.0 
No. of 
rabbits 
lo 
No. showing 
local  No. of 
Shwattzman  deaths 
reactions 
1(2)  5 
7  o 
--  o 
--  o 
--  o 
Typhoid endotoxin  was undiluted sterile filtrate. In additional titrations, concentrations 
of erythrogenic  toxin up to 15 Lf did not prepare for the local Shwartzman  reaction. 
the  erythrogenic toxin.  The  same  applies  to  the  SLE  toxins.  To  eliminate 
the  possibility of  contamination with  Gram-negative  bacterial  endotoxins, 
advantage is  taken of two properties  of the erythrogenic toxins not shared 
with endotoxins. One of these, specific immunization, both active and passive, 
has been demonstrated in several previous experiments with SLE-toxins. The 
second property, originally observed by Schwab et al.,  (4,  5) is the ability of 
SLE when injected intradermally, to enhance the lethal and tissue-damaging 
properties of toxins.  In contrast, endotoxins from Gram-negative bacteria or 
streptococci (13) given intradermally induce the local Shwartzman reaction. 
It was of importance, therefore, to compare Stock's erythrogenic toxin with 
a  known  Gram-negative  bacterial  endotoxin  with  respect  to  its  ability to 
enhance the lethality or prepare  for the local Shwartzman reaction. Results 
given in Table III show that erythrogenic toxin, given intradermally, enhanced 
the lethal and tissue-damaging properties of typhoid endotoxin as manifested 
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vivors when examined 3 days after the injection of typhoid toxin; local Shwartz- 
man  reactions  were  not  observed.  On  the  other  hand,  typhoid  endotoxin 
given intradermally produced  local Shwartzman  reactions in  7  of the  10  ani- 
mals and none died or appeared ill. 
These results confirm our original observations and  relate SLE  activity to 
that  of erythrogenic toxin;  therefore,  this ability of erythrogenic toxin when 
given  intradermally,  to  enhance  the  lethal  and  tissue-damaging property  of 
typhoid endotoxin rather  than  to prepare  the  skin for  the  local Shwartzman 
reaction, is the basis of another method  for differentiating these scarlet fever 
toxins from other exogenous and endogenous pyrogens. 
Preparation  and  Purification  of Streptococcal Exotoxins in  Vitro 
Lesion  extracts  such  as  SLE  are  ideal  sources  in  which  to  demonstrate 
important  parasite  factors;  they  are not,  however,  suitable for  isolation and 
purification  studies  because  their  relatively high  content  of  serum  proteins 
make  purification  or  concentration  difficult.  Therefore,  the  experiments  de- 
scribed here  are preliminary to  a  subsequent  study  designed to produce  and 
isolate these  toxins from in vitro sources.  As already pointed out,  Stock  and 
his associate (10)  have made valuable  contributions  in  this  area,  specifically 
toward  the  isolation and  characterization of  the  A  toxin and  more  recently 
toward the isolation of the B  toxin (16). 
Methods used in this phase  of  the  problem  have been those which  will not 
dissociate  natural  complexes.  So  far  we  have  found  a  close  association be- 
tween the toxin and  hyaluronic acid.  Whether  or not  this  has  any  biological 
significance is  of  particular interest  for  the  future.  For  these  reasons,  ultra- 
filtration and  electrophoretic methods  were  used  at  hydrogen-ion  concentra- 
tions  and  ionic strengths  which  at  least approach  the physiologic conditions 
of the  host. 
Production of Toxin.--NY-5  streptococci  grown for  18 hours  from  the lyophilized state 
in 10 ml. amounts of modified Stock's medium were transferred in 1 to 2 ml. quantities to 
flasks containing 100 ml. of this medium. After incubation for approximately  8 hours at 37°C., 
the entire culture of 100 ml. was transferred to flasks containing  1500 ml. of the media; these 
had previously been brought to 37°C. Within 5 to 6 hours, the culture completes the logarith- 
mic phase of growth.  Short incubation periods were chosen  to minimize contamination of 
the extracellular with intracellular products derived from  lysed cells.  Cell-flee filtrate ob- 
tained by passing the culture through an electrically driven Sharples centrifuge  and a Seitz 
sterilizing filter was concentrated on ultrafilters at I°C. (17). Alundum thimbles were coated 
with parlodion dissolved in concentrated glacial acetic acid at a concentration of 6 per cent. 
The concentrated material was washed on the ultrafilters with several liters of pyrogen-free 
distilled water. The highly viscous material, washed off the ultrafilters with distilled water, 
was placed in Visking cellulose casing and dialyzed with continuous stirring against pyrogen- 
free water at I°C. for 3 days to remove low molecular  weight--contaminatlng constituents 
of the medium. It was assumed that they would be removed by this procedure since they had 
originally passed through the same  membrane  during the preparation of the medium. The 270  DENNIS  W.  WATSON 
dialyzed produce was now finally brought to dryness by lyophilizatlon. This crude material 
was  highly pyrogenic and  enhanced  the lethality of Gram-negative endotoxins.  A yield of 
2.2 gm. from 20 liters of medium was obtained. 
Electrophoretic Purification.--When 0.5 per cent concentrations of the crude preparation 
were run in an Aminco Tiselius-type electrophoretic cell,  the results recorded in Text-fig. 9 
were obtained. The high viscosity prevents the use of higher concentrations.  In this concen- 
tration,  there were two main components.  As indicated by the areas under  the curves, hy- 
aluronic acid is the major component in these crude preparations; a second  component of low 
mobility at  this pH and ionic strength  appeared  to contain the toxin. Since there were two 
main components, it was possible  to remove the fast moving component from the ascending 
TExT-FIG.  9.  Electrophoretic  pattern  of  streptococcal  (NY-5)  extracellular  products. 
The concentration was 0.5 per cent in veronal buffer at pH 8.6 and ionic strength 0.1.  Com- 
ponent  (T)  had an apparent  isoelectric point of 7.2 determined from a  pH mobility curve. 
Below pH 7.2 there was visible complexing with hyaluronic acid (H). For isolating (A) electro- 
phoresis was continued until  (H)  reached the bottom of the descending arm of the cell. 
limb of the cell and the slow moving from the descending.  This was accomplished by the use 
of polyethylene (0.067"  O.D.) intravenous tubing attached to a  10 ml. syringe. By visualiza- 
tion through the optical system,  the end of the polyethylene tubing could be observed  and 
the components easily removed. The absence of observable components does  not of  course 
preclude the possible  existence of other  extracellular products  at  concentrations below  the 
resolving power of the optical system.  Fraction A, shown in Text-fig. 9 contained all of the 
extraceUular products after  the  removal of hyaluronic acid (//);  this fraction was  dialyzed 
against distilled water and concentrated by lyophilization. Fractions from several runs were 
pooled  to  give  sufficient  material  for  testing. 
Agar Diffusion Precipitin Analysis.--The  Ouchterlony  technique  was  used 
to compare,  serologically, fraction A  with Stock's erythrogenic toxin and sonic 
extracts  of  NY-5  and  Type  18  cells.  The  results  given  in  Text-fig.  10  show 
reaction  of  identity  between  fraction  A  and  Stock's  toxin.  This  commercial 
antisera obviously contains a  number of antibodies to intracellular constituents 
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of identity with any of the intracellular components. More critical use of the 
Ouchterlony technique may resolve more  than one  system in Stock's  toxins 
and fraction A. Regardless of this possibility, the major component in fraction 
A is definitely related to Stock's toxin. 
Pyrogenicity  of Toxin in Fraction A, Its Lethal Enhancement  and Erythrogenic 
TExT-FIe-. 10. Agar diffusion precipitin analysis of streptococcal extracellular and intra- 
cellular components. The lettered  wells in the Ouchterlony plate contained: E, commercial 
scarlet fever antitoxin (Wellcome Laboratories) 0.2 ml.; A, fraction A (Text-fig. 9), 0.2 ml. of 
a solution containing 2 mg. in 0.5 ml. of 0.85 per cent NaC1 solution; D, Stock's exotoxin 
0.2 mh of a solution containing 560 Lf/ml.; F,* sonic extract of washed NY-5 streptococcal 
cells 0.2 ml.; B,* sonic extract of washed Type 18 streptococcal cells, 0.2 ml.; G and C were 
not significant to the experiment. Differences in the position of lines in the two experiments 
and the greater resolution with sonic extract of Type 18 cells can be explained by the longer 
time of diffusion in the A, B, C, D plate. 
Activity.--To  relate  the  toxin  in  fraction  A  with  SLE  toxins  and  Stock's 
erythrogenic toxin, it was  tested for pyrogenicity and lethal enhancement of 
typhoid endotoxins. Results of these tests given in Table IV indicate that the 
electrophoretically isolated fraction A  is highly active as  a  pyrogen and en- 
hances the lethality of Gram-negative bacterial toxins. 
Like  Stock's erythrogenic toxin, it gives no reaction even at  15  ~g.  in the 
skin of  the  American Dutch  rabbit.  When tested  in  the  skin of  5  humans, 
0.01  ~g.  of  Stock's  toxin gave reactions showing edema and erythema; these 
* Cells obtained  from the  Sharples centrifuge during the  preparation  of the  toxin were 
washed  and  resuspended  in  distilled  water.  A 22 per cent suspension was placed in the 
Raytheon for 3 hours at 9000 kc./sec, at a temperature of 6°C. Cell debris was removed by 
centrlfugation at  12,800 G.  for 90 minutes. The supernatant,  after  passing through  an 02 
Selas filter was stored in sealed ampoules at -70°C. These extracts were kindly prepared by 
Miss Natalie  Cremer of  this  laboratory. 272  DENNIS W.  WATSON 
appeared in 24 hours and varied in size from 15 X  20 ram. to 50 X  65 ram. On 
a  comparative basis  in  a  single  individual, fraction  A  at  a  concentration  of 
0.01  #g.  gave a  reaction in  the left arm  measuring 35  X  40  mm.,  while the 
reaction to Stock's toxin in the right arm at the same concentration, measured 
50 X  65 mm. 
Consideration  of Other  Streptococcal  Factors 
The most probable toxic component of SLE preparation would be streptolysin 
0  or S. SLE preparations, however,  do not contain either active streptolysin 
TABLE IV 
Pyrogenicity of Toxin in Fraction A and Its Lethal Enhancement of Typhoid Endotoxin 
Temperature 
First injection  fraction  A  > I°F. after  Second  injection  typhoid  filtrate  Dead/total 
3 hrs. 
/Zg. 
15 
10 
5 
2.5 
1 
ml. 0.85 per cent NaCl solution 
3/3 
2/3 
2/3 
1/3 
0/3 
0/4 
0/4 
ml. 
0.25 
0.25  +  5 #g. fraction A 
0.25 +  15 #g. fraction A 
3/3 
3/3 
2/3 
3/3 
1/3 
0/4 
1/4 
Fraction A  dissolved  in  0.85 per  cent  NaCl solution was  injected intravenously into 
rabbits. Temperatures were recorded before and 3 hours after injection. Three animals were 
used for each concentration of toxin and those given in the nominator had temperature in- 
creases in excess of I°F. 3 hours  after injection.  The controls received saline first injection 
and typhoid toxin plus fraction A 3 hours later. The failure of the combined  toxins to pro- 
duce significant lethality when compared with the activity observed when given singly at a 
3-hour  interval indicates that  this phenomenon  is a  true enhancement  and not a  simple 
additive effect. 
O  or S  or inactive streptolysin O,  determined  by  the  addition of a  reducing 
agent  such  as  cysteine. When  the  Group  A  streptococci grow  in  the  skin of 
rabbits, there is an extravasation of red cells into the lesions with subsequent 
lysis of these cells. In other words, one might postulate that there is sufficient 
substrate available to absorb  these lyric toxins.  Stock's toxin and fraction  A 
contained no detectable streptolysins when tested with conventional hemolytic 
methods controlled by the use of known streptolysins. 
Another  interesting  streptococcal product  described by  Carlson  et  al.  (18) 
is  diphosphopyridine  nucleotidase  or  DPNase;  this  enzyme  is  closely  asso- 
ciated with  streptolysin O.  It was  of  interest  to  determine  its presence  and 
possible implication in the toxic manifestations of SLE. Several SLE prepara- 
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ase activity by the method of Kaplan et d. (19). Table V shows that the nephri- 
togenic  Type  12  strain  produces  significant  quantities  of  DPNase  in  v/vo. 
Types 18,  19, and NY-5-SLE preparations  contained no detectable  DPNase; 
these results are in accord with  those reported  for the in vitro production of 
enzyme by these types (18). The absence of this enzyme in highly toxic SLE-18, 
TABLE V 
Diphosp~pyridi~ Nud.eotidase (DPNase) Aai~ty* of SLE-Pr,paraJions 
SLE  DPNa~ 
SLE 12-1 ............................................ 
SLE 12-2  ............................................. 
SLE 12-3 ............................................ 
SLE 12-4  ............................................ 
SLE-18 .............................................. 
SLE-19 .............................................. 
SLE-NY-5 ........................................... 
n~i~s/r~g. 
375 
38O 
520 
545 
215 
220 
150 
155 
SLE-12 was made  with  a single type 12 streptococcus.  Nos.  1 to 4 represent  different 
preparations  of SLE-12. The values given for DPNase activity are duplicate determinations 
on samples from the same lot. 
* These determinations  were kindly  made by Mr. Richard  Hyde of this laboratory. 
-19, and -NY-5 excludes  this factor as the active toxin in SLE. It is not im- 
possible,  however,  that  the  pyrogenic  exotoxins  of  SLE  may  enhance  any 
toxicity attributed to this enzyme in the same way that it enhances the lethality 
of streptolysin O and Gram-negative bacterial toxins. 
The only component observed in fraction A  other than  erythrogenic toxin 
was  desoxyribonuclease  or  DNase.  Determinations s  revealed  a  significant 
quantity of the enzyme in contrast to the absence of active enzyme in Stock's 
s These determinations were kindly done by Mr. Howard Pierce in Dr. L. W. Wannamaker's 
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erythrogenic toxin.  Since  fraction A  and  Stock's erythrogenic toxin  had  the 
same pyrogenic activity, it can be concluded that the DNase was not contrib- 
uting to the toxicity of fraction A. 
TABLE VI 
Rdationship of Stock's Erytkrogenic Toxin to SLEoToxins Determined by Cross-Immunization 
Immune/total  when tested with 
Rabbits immunized 
with 
Stock's  SLE 18  SLE NY5 
toxin 
Stock's  erythro- 
genic toxin 
SLE-18 
SLE-12 
SLE-NY5 
SLE-19 
SLE-17 
SLE-28 
SLE 12 
11/12  1/12  8/12  1/8 
(0/5)  (1/9)  (2/10)  (1/6) 
12/12  1/8 
(o/6)  (2/lO) 
10/10  0/4  9/10  2/7 
(0/5)  (2/6)  (3/i0)  (1/6) 
SLE 19  SLE 17  SLE 28 
1/11 
(o/9) 
2/8)  1/8  1/12 
(1/s)  (o/8)  (2/lO) 
2/10  8/10 
(O/8)  (0/10) 
618  0/8  7/8  6/6  7/7  7/8 
(2/10)  (1/9)  (0/6)  (1/6)  (0/9)  (1/8) 
1/9  7/9 
(0/9)  (0/9) 
2/8  7/8  o/8 
(0/10)  (0/8)  (1/9) 
0/9  7/10 
(0/9)  (2/10) 
7/8  7/8 
(0/8)  (0/10) 
lO/lO 
(2/lO) 
On the average,  daily intravenous  injections  of the toxins immunized the rabbits.  A 
single immunizing or test dose of Stock's toxin,  diluted  in 0.85 per cent NaC1, contained 
0.125 Lf in 0.5 ml. Immunizing  and test doses of the SLE preparations  were undiluted;  a 
single dose between 0.5 and 0.8 ml. depended on the pyrogeniclty of the SLE. Animals were 
considered immune when their  temperatures  did not increase over I°F. 3 hours after receiv- 
ing the test dose of toxin intravenously.  The bracketed results represent  the febrile response 
of normal  animals given the test dose of toxin at the same time as the immunized group; 
as shown, 2 of 10 normal animals may appear  refractory to the toxin. 
Identification  of Exotoxins by Specific Immunization  against  Their  Pyrogenic 
Effects 
Evidence  presented  in  this  paper  related  the  fever-inducing  ability  and 
other effects of SLE preparations to the group of toxins represented by Stock's 
erythrogenic toxin. A  serologic or immunocbemical test would be desirable  for 
the  identification  of these  toxins in SLE. Their  relatively  low  concentration 
and close association with other antigenic extracellular  products,  such as one HOST-PARASITE  ~ACTORS  IN  GROUP  A  STREPTOCOCCAL  INFECTIONS  275 
or more of three immunologic distinct DNases (20) as shown by Halbert (21) 
makes a serologic test difficult until methods of production in vitro and purifica- 
tion are  achieved.  In  the  meantime, a  measurement of their  activity and 
specific neutralization by active immunization in rabbits can be  utilized to 
identify immunologically specific toxins within this group.  The technique has 
been fully outlined and the results for SLE-18 and -28 are given in Text-fig. 3. 
In addition, it was of interest to determine whether the pyrogenic assay for 
specificity of these toxins could be correlated with the skin-neutralization test. 
By the use of this latter test, Coffey (22) recognized the multiplicity of these 
toxins, and Hooker and Follensby (23) found 2 toxins in NY-5 filtrates which 
they designated A and B. 
TABLE  VII 
Immunologic Distinct Exaoxins Produced in ~i~o by Various  Types of Group A  Streptococcl 
Type of streptococcus 
~-5-10 
18 
28 
12 
17 
19 
A 
+ 
+ 
+ 
+ 
Type of toxin* 
+ 
+ 
C 
+ 
* Nomenclature of Hooker  and  Follensby  (23). 
The data given in Table VI show that Stock's toxin immunized against the 
effects  of  the  homologous  challenge  and  SLE-12  but  not  against  SLE-18, 
SLE-NY-5 or SLE-19. Since Stock's toxin prepared from NY-5 is the A toxin, 
failure to immunize against SLE-18, -NY-5, and -19 could be accounted for by 
either the presence of 2 toxins in these SLE preparations or an immunologic.ally 
distinct toxin.  Immunization with SLE-NY-5  indicated the presence  of two 
toxins as previously shown (23). Indeed, it immunized against all of the SLE- 
toxins with the exception of SLE-18. The failure of SLE-toxins,  except NY-5, 
to immunize against SLE-19,  indicated that  SLE-19  contained only the  B 
toxin.  It can be seen that SLE-12, -17, and -28 are related to Stock's toxin 
and, therefore, contain only the A toxin. SLE-18 produced an immunologically 
distinct toxin not related to either A or B. To continue the nomenclature of 
Hooker and Follensby (23), this new toxin was designated C. Small amounts 
of the C toxin were produced in vitro;  further characterization of this toxin is 
in progress. 
Table VII gives the types of toxins produced by the various Group A strepto- 
cocci tested. From the results with SLE-NY-5, it is evident that the pyrogenic 276  DENNIS W. WATSON 
assay is  measuring  the same  activity as  originally  obtained  with the skin- 
neutralization test. 
Among the Group A streptococci  tested, the A toxin is the most common. 
It is interesting that the more recently isolated Types 18 and 19 produce  the 
C and B toxins, respectively; the nephritogenic Type 12 strain, however, makes 
the A toxin. Indeed, it will be interesting to correlate  the types of toxin with 
the serologic types and to determine whether or not there are additional distinct 
toxins especially in the more recently isolated epidemic types. 
DISCUSSION 
This investigation, designed to discover new factors important in the patho- 
genesis of Group  A streptococcal  infections  and their sequelae,  has demon- 
strated a new activity associated with a familiar group of substances  commonly 
referred to as Dick, scarlet fever, or erythrogenic toxins. The following discus- 
sion relates these findings to the classical reactions of these toxins and develops 
the concept that they damage tissue  and modify the host-response  to injury 
in a manner not previously recognized. 
Soon after Dicks (24) and Dochez and Sherman (25) discovered scarlet fever 
toxin its toxicity for rabbits was described (26, 27). The time of death and the 
gross pathology resembled in some ways the results given here where Stock's 
toxin was titrated in American Dutch rabbits. In the past, few studies have 
been concerned  with the lethal and tissue-damaging  properties  of the scarlet 
fever toxins.  Perhaps the importance of these toxins  was minimized because 
immunization with a single toxin as antigen did not confer protection against 
infection; it was reasoned, therefore, that the toxin must not play a role in the 
pathogenicity of the Group A streptococci. The reasoning, based on the diph- 
theria toxin analogy, neither took into consideration  the multiplicity of im- 
munologicaUy distinct toxins  nor did it recognize that an organism  such as 
the streptococcus may not use one or more of its toxins in a single attribute of 
virulence  such as infectivity. Even now, there is not complete  agreement on 
the mechanism by which the toxins induce  a rash in the Dick test and scarlet 
fever. The Dicks and others (28, 23) attributed the rash to a primary toxicity; 
others  (29, 30)  presented good  evidence  that  the erythematous lesions are 
allergic reactions either to the toxins or other products of the streptococci. 
More recently, Rantz, Boisvert and Spink  (31) favored the latter conclusion 
after studying the Dick test in men of military age. Positive reactions were 
less frequent in personnel  from geographical areas with a reported/ow~ inci- 
dence of streptococcal  disease. They suggest  that the skin  sensitivity in the 
Dick test results from acquired  hypersensitivity to a  streptococcal  product 
and not from the natural susceptibility to a true toxin. 
The present results interpreted in the light of earlier  studies,  bring  these 
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(900,000 STD)  of purified  scarlet  fever  toxin gives no reaction in the skin. 
Dochez and Stevens in 1927 (29) made a similar observation; they made the 
logical correlation between hypersensitivity and activity when their normally 
refractory  rabbits  became  skin-sensitive  after  streptococcal  infection.  It 
follows, therefore,  that if skin activity is the only criterion  of toxicity, scarlet 
fever toxin is not a toxin in our host. If, however, one uses the parameters of 
toxicity such as death, fever response, increase in serum transaminase, enhance- 
ment  of  the  lethal  and  cardiotoxic  properties  of  Gram-negative  bacterial 
endotoxins,  as set forth in this and previous  papers,  then one must conclude 
that these are true toxins,  in this host, not dependent on the acquisition  of 
hypersensitivity. 
Boroff (32) described an interesting observation  which, at the time, did not 
seem  pertinent  to  our  studies because  SLE-toxins  elicited  no  erythrogenic 
activity in American Dutch rabbits. He showed that erythrogenic toxin, given 
into the skin of sensitive rabbits at 24-hour intervals, markedly enhanced the 
erythrogenic  and  nephrotoxic  properties  of  the  toxins.  Undoubtedly  the 
enhancement activity Boroff described  in the skin is manifested here in the 
results on lethality and tissue damage. These combined observations  describe 
the most interesting toxic property of erythrogenic toxins; given either intra- 
venously or  intracutaneously, they modify the  host-response  to  injury to 
themselves  (see Table II and Text-fig. 1) and other toxins (Text-fig. 8). That 
hypersensitivity reactions  of the anaphylactic type can be enhanced by these 
toxins was given in a preliminary report (33). It is not known whether Boroff's 
observations are an enhancement of an acquired  hypersensitivity to the toxin 
or closely associated protein (34), an enhancement of a true toxicity within the 
skin or a mixture of both, depending  on the previous  experience of the host. 
This basic  information must be obtained before the mechanism  of  the Dick 
test or the rash in scarlet fever can be resolved. 
Another significant manifestation of a modified host-response brought about 
by treatment with  SLE-toxins  and  streptolysin O  was  reported by  R~tska 
and Rotta (35); after confirmation of our earlier report (4), they showed that 
in toxin-treated animals,  Group  A  streptococci  given  intranasally persist  in 
the lungs,  myocardium, and kidneys; normal animals given  streptococci  by 
the same route failed to become infected.  The importance of factors which 
control the entrance and persistence  of organisms in tissues is obvious,  espe- 
cially if the interesting cell-wall toxin (36) can be implicated in the evolution 
of the rheumatic lesion. 
The pyrogenic response invoked in American Dutch rabbits by erythrogenic 
toxin present in SLE was  the most useful  parameter of toxicity. Failure to 
find significant quantities of other endogenous and exogenous pyrogens in the 
SLE was unexpected.  Indeed, one would expect to find the endogenous pyrogen 
of Landy and Shear (37); either the Group A streptococci do not liberate this 278  DENNIS  W.  WATSON 
toxin from rabbit skin or the toxin is destroyed within the lesion. The endog- 
enous pyrogens of Atkins and Wood (38) and Bennett and Beeson (39) would 
not be expected in high quantities, especially if they arise from leucocytes. As 
pointed out earlier,  the streptococcal lesions are not purulent. Although highly 
pyrogenic,  the  relatively small  amount  of  Stetson's  (13)  endotoxins  in  the 
Group A streptococci combined with minimal lysis of the streptococci within 
the lesion perhaps explains  the failure to detect them in the SLE-preparations. 
Stetson's  failure  to  obtain  complete  cross-tolerance  between  streptococcal 
endotoxin and  Gram-negative bacterial endotoxin could be explained by the 
assumption  that  his  streptococcal  lysate  contained  an  active  quantity  of 
erythrogenic toxin (see Text-fig.  4). 
Results obtained, using the Ouchterlony technique employing an antiserum 
with  a  multiplicity  of antibodies  to  streptococcal  cellular  and  extracellular 
products,  indicate  that  Stock's  toxins  and  the  electrophoretically  purified 
toxin are identical; from the significant  work of Halbert (21) and Wannamaker 
(20) one could predict that they contain small amounts of other streptococcal 
products.  Erythrogenic  toxin is closely associated with streptococcal DNase 
(21).  The  electrophoretically purified  preparation  described  here  contained 
active DNase,  but Stock's preparation  had  no detectable enzymic activity. 
Likewise  SLE-toxins  prepared  with  a  nephritogenic  Type  12  contained 
DPNase; others prepared with Type 18 had no activity. This type of indirect 
evidence indicates that neither DNase nor DPNase play a  direct role in the 
toxicity attributed to erythrogenic toxins.  Further purification and character- 
ization of these toxins is the ultimate goal; once attained, however, one must 
recognize  that  the  Group A  streptococcus does not present the host with a 
single purified  toxin.  Indeed, as shown here and previously for streptolysin O 
(40) streptococcal endotoxin (13) and SLE-toxins (4, 5), the sequence in which 
the host receives the toxins may be a critical determinant in the host-response 
to injury. 
The mechanism by which these toxins cause tissue damage is not known. In 
some respects the activity resembles that of Gram-negative bacterial endotoxin. 
The recent interesting results from Russia (41) on the physiologic response of 
rabbits  to  purified  erythrogenic  toxin  may  suggest possible mechanisms  of 
action. In addition to the pyrogenic effects noted here, blood sugar and adren- 
alin  increased  and  reached  a  maximum  in  approximately 30 minutes  and  3 
hours respectively. 
The histopathologic studies on tissue from rabbits given one  and/or  two 
spaced injections of erythrogenic toxin are of interest; these changes indicate 
the ability of such toxins to produce significant  damage in various tissues of 
the host including  the mitral valve; there is neither an indication of specificity 
for this structure within the heart nor a  suggestion  that the lesions resemble 
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logically,  more significant  lesions have been observed by others (42-44).  It is 
significant  to note, however,  that the results of these investigations were ob- 
tained in rabbits with living streptococci multiplying in an in vivo environment. 
Conditions would be ideal for the production of the exotoxins described in this 
communication. 
Most of these investigators placed primary emphasis on the development 
of the Aschoff body as the final criterion in the identification of a rheumato- 
genic factor. Another approach, discussed  briefly by Rantz (45) suggests that 
appropriate biological  methods, such as immunization,  might induce a resist- 
ance in human tissues to the development of the rheumatic process even though 
Group A  streptococcal infection occurs.  As an example,  he cites  the 8 year 
controlled study of Wasson and Brown (46); they injected Valdee's (47) tannic 
acid-precipitated  erythrogenic  toxin  into  rheumatic  subjects.  The  results 
appear  significant  as indicated by the fall  in  the incidence  of rheumatic  re- 
crudescence in the immunized  groups. The production of additional immuno- 
logic distinct toxins by the Group A streptococci has special significance in the 
evaluation of these results. While the A and B toxin used by Brown and Wasson 
are produced most frequently by Group A  streptococci (Table VII),  an epi- 
demic type such asl8, isolated from naval personnel at Great Lakes, can produce 
another  toxin as represented  by Type C. As predicted by Hooker and  Fol- 
lensby (23),  undoubtedly others exist. It is obvious, therefore, that antigenic 
preparations  used  to  confirm  the  efficacy  of such  immunization  procedures 
should include the known toxins and  those not yet identified within  the re- 
maining types of Group A streptococci. 
Finally as a working hypothesis, it is proposed that most Group A strepto- 
cocci  growing  in  the  in  vivo environment  of the  host  produce one or  more 
immunologically distinct toxins associated with the scarlet fever toxins.  Trans- 
ferred from the host to culture media, the organisms may or may not continue 
to produce the toxins. In the past, only those types capable of producing toxin 
in vitro were considered toxigenic.  The primary activity of the toxins concerns 
their  ability to  modify the  host-response  to  injury  to  themselves,  to  other 
toxins,  and to toxic reactions such as hypersensitivity. The absence of a rash 
in an infected individual does not preclude damage to other tissues by these 
toxins. Rash is manifested only in those individuals sensitized as a  result of 
antecedent Group A streptococcal infections.  Immunization against  all  of the 
possible immunologic  types of toxins produced by the Lancefield  Group  A 
streptococci may protect the tissues against critical injury even in the presence 
of infection. 
It  must  be recognized  that  the results  and  concepts presented  here  were 
derived from experience  with a single experimental host, the American Dutch 
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contribute by analogy to the understanding of data directly concerned  with 
Group A streptococcal infection in man. 
SUMMARY 
The factors present in streptococcal  lesion extracts (SLE) which enhanced 
the lethal and  tissue-damaging  properties  of Gram-negative  bacterial  endo- 
toxins and streptolysin O were identified with the scarlet fever group of toxins. 
Toxic manifestations attributed to this group of toxins included lethality, 
cardiotoxic and other tissue damage, enhancement of toxicity, and pyrogenic- 
ity. Of these,  the measurement of febrile response in American Dutch rabbits 
was the most useful parameter of toxicity. 
In rabbits, repeated daily intravenous injections of 0.125 Lf of a  purified 
erythrogenic toxin immunizes specifically against the pyrogenic activity; this 
technique was used to type the toxins and to distinguish them from exogenous 
and endogenous pyrogens; non-specific pyrogens,  such  as streptococcal  endo- 
toxin, were not found in SLE. 
All types of the Lancefield  Group A streptococci  tested produced one  or 
or more immunologically distinct toxins in vivo in contrast to Groups B and C 
which  did not produce  them; toxins  A and B, previously distinguished  by 
neutralization of rash-inducing activity in the skin, were produced in v/vo. The 
A toxin was the most common, as indicated by its presence in extracts prepared 
with Types 28, 12, 17, and 10 (NY-5);  B toxin was found in 10 (NY-5)  and 
19. A new toxin, designated C, was obtained from a Type 18. 
In  American  Dutch  rabbits,  purified  toxin  at  a  concentration of  15  Lf 
(900,000 STD)  neither gave a  Dick test nor prepared the skin for the local 
Shwartzman reaction; by this route, however,  in contrast to classical endo- 
toxins,  they enhance the lethal and tissue-damaging  properties  of  sublethal 
doses of these and other toxins. 
These properties  of the immunologic distinct exotoxins as demonstrated in 
American  Dutch rabbits suggest  by analogy their importance in the patho- 
genesis of streptococcal  disease in man. Evidence that might implicate  them 
in sequelae, in addition to scarlet fever, is discussed. 
The author is indebted to Mr. Luther Towner for excellent technical assistance. 
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EXPLANATION OF PLATE 20 
All sections were stained with hematoxylin and eosin. 
FIG. 1.  Section from the mitral valve of a  rabbit given 0.75 ml. of SLE-18 intra- 
venously followed in 3 hours with 15 Lf of Stock's erythrogenic toxin intravenously. 
The animal died in 24 hours. The valve appears edematous, and there is a moderate 
increased cellularity. X  70. 
FIG. 2.  Section from the myocardium of a rabbit killed 4 days after administration 
of 0.5 ml. of SLE-18 intravenously followed in 3 hours with  15 Lf of Stock's erythro- 
genic toxin. The section shows an extensive area of muscle necrosis with calcification 
of necrotic fibers, but there is no inflammatory reaction. X  70. 
FIG. 3.  Section from  the myocardium of a  rabbit given 0.5  ml. of  saline intra- 
venously followed in 3 hours with 15 Lf of Stock's erythrogenic toxin. The animal was 
killed 4  days after injection. There is  extensive muscle necrosis accompanied by a 
pronounced  cellular  reaction  which  consists  predominantly  of  mononudear  cells. 
X  70. 
FIG. 4.  Section from the liver of a  rabbit which was killed 2 days  after adminis- 
tration of 0.5 ml. saline followed in 3 hours with 15 Lf of Stock's erythrogenic toxin. 
The section shows a  large infarct, surrounded by a  heavy zone of hemorrhage and 
inflammatory cells. X  320. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  111  PLATE 20 
(Watson:  Host-paraslte  factor  in  Group  A  streptococcal  infections) 